Social Media in Medicine

Top 10 healthcare social media predictions

3 of my predictions appeared here: Industry consultant and entrepreneur Jane Chin (@janechin) goes even further, alleging that next year PhRMA will appoint its first ever ‘Chief Tweeting Officer.’ Jane Chin (@janechin) thinks social media will spur new approaches to customer care and technology, as “cutting edge pharma …companies will experiment with a blend of [...]

Read the full article →

Pharma Industry’s Job is NOT Disease Prevention. THAT’S YOUR JOB.

I’ve heard the argument, so have you. “Those evil pharma companies aren’t interested in prevention! They want people to get sick and stay sick because that’s how they make their money! On the drugs!” Recently I had railed against the pharma companies that are capitalizing on increasing trends of people using certain prescription drugs as [...]

Read the full article →

Female Sexual Dysfunction: Pharma’s Next Lifestyle Market

I’m posting this from one of Steve Woodruff’s blog posts that I shared via my Facebook profile, which turned into a full blown debate between me, Dmitriy Kruglyak, and Yvette – one of my FB friends. Jane Chin I’m pro-pharma, but I’m NOT happy w/ female sexual dysfunction disease mongering I expect to see from [...]

Read the full article →

How to See Through Pharma Ad BS?

Like all marketing campaigns, the aim of any pharma advertisement is to get you to think that you need a certain product or a service. I understand that all pharma companies will say that they want to educate patients on the condition first and foremost, but I guarantee that when pharma companies are forking over [...]

Read the full article →

How Useful is Social Media in Pharmacovigilance?

By Jane Chin, Ph.D. In theory, engaging social media in pharmacovigilance is attractive, if not sensible. In practice, engaging social media in pharmacovigilance will be fraught with such high noise-to-signal ratio that both pharma companies and regulatory agencies may struggle to embrace it. Let’s look at how pharmacovigilance has fared from the field perspective. We [...]

Read the full article →

Next Entries →